Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series

Objectives: The prognosis for metastatic cervical cancer has dramatically improved in the past years with the addition of anti-PD1/PD-L1 immunotherapy to standard platinum-based chemotherapy +/-bevacizumab. Here, we aimed to investigate the benefit from combining chemo-immuno-radiotherapy for metast...

Full description

Bibliographic Details

Published in:	Gynecologic Oncology Reports
Main Authors:	Thomas Westerhoff, Nathalie Baudoux, Manuela Undurraga, Patrick Petignat, Intidhar Labidi-Galy, Melpomeni Kountouri
Format:	Article
Language:	English
Published:	Elsevier 2025-10-01
Subjects:	Cervical cancer Metastatic Immunotherapy Chemo-radiotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578925002929